Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in RCEL held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 82.0M | $197.0M | β | 330.118% | 4.15% |
| 2 | EverSource Wealth Advisors, LLC | 102K | $9.7M | β | 0.412% | 0.30% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 1.3M | $4.9M | β | 5.374% | 0.00% |
| 4 | BlackRock, Inc. | 1.1M | $4.2M | +5.0% | 4.561% | 0.00% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 543K | $2.0M | +13.3% | 2.186% | 0.00% |
| 6 | STATE STREET CORP | 429K | $1.6M | +2.6% | 1.727% | 0.00% |
| 7 | VANGUARD FIDUCIARY TRUST CO | 193K | $716K | β | 0.779% | 0.00% |
| 8 | NORTHERN TRUST CORP | 183K | $678K | +12.1% | 0.737% | 0.00% |
| 9 | MORGAN STANLEY | 158K | $583K | +5.3% | 0.634% | 0.00% |
| 10 | Divisadero Street Capital Management, LP | 100K | $370K | 0.0% | 0.402% | 0.02% |
| 11 | GOLDMAN SACHS GROUP INC | 100K | $369K | +23.9% | 0.402% | 0.00% |
| 12 | AQR CAPITAL MANAGEMENT LLC | 94K | $349K | -7.0% | 0.380% | 0.00% |
| 13 | VANGUARD PORTFOLIO MANAGEMENT LLC | 82K | $305K | β | 0.331% | 0.00% |
| 14 | UBS Group AG | 62K | $231K | -30.8% | 0.251% | 0.00% |
| 15 | BANK OF AMERICA CORP /DE/ | 62K | $230K | +145.3% | 0.250% | 0.00% |
| 16 | MARSHALL WACE, LLP | 53K | $194K | β | 0.212% | 0.00% |
| 17 | STRS OHIO | 48K | $176K | 0.0% | 0.192% | 0.00% |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 46K | $171K | +0.1% | 0.186% | 0.00% |
| 19 | Nuveen, LLC | 42K | $157K | +1.0% | 0.171% | 0.00% |
| 20 | THOMPSON DAVIS & CO., INC. | 39K | $144K | β | 0.157% | 0.10% |
| 21 | DEUTSCHE BANK AG\ | 32K | $117K | +301.9% | 0.128% | 0.00% |
| 22 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 30K | $112K | -74.2% | 0.122% | 0.00% |
| 23 | Bank of New York Mellon Corp | 30K | $110K | 0.0% | 0.120% | 0.00% |
| 24 | AMERIPRISE FINANCIAL INC | 29K | $106K | -1.3% | 0.116% | 0.00% |
| 25 | FMR LLC | 29K | $106K | +978.6% | 0.115% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in RCEL β a direct measure of their conviction.
Filings activity in RCEL during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 76 | +15% | 199.99% | +182.91 pp | $226M | +1260% |
| Q4 2025 | 66 | 9.6% | 17.08% | 9.26 pp | $17M | 35% |
| Q3 2025 | 73 | 7.6% | 26.34% | 14.82 pp | $26M | 36% |
| Q2 2025 | 79 | +5.3% | 41.16% | 17.52 pp | $40M | 30% |
| Q1 2025 | 75 | +4.2% | 58.68% | 23.72 pp | $57M | 29% |
| Q4 2024 | 72 | +9.1% | 82.40% | +17.05 pp | $80M | +26% |
| Q3 2024 | 66 | 2.9% | 65.35% | +16.07 pp | $63M | +33% |
| Q2 2024 | 68 | β | 49.28% | β | $48M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Latest Form 4 transactions by company officers and directors. Insider buys are widely viewed as the highest-conviction signal because executives are risking personal capital.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2026 | Woody Joseph Fralin | Buy | 5K | $4.34 | $22K |
Quick answers to the most common questions about buying RCEL stock.
Based on Q1 2026 13F filings, institutional ownership of AVITA Medical, Inc. stands at 200.0%, held across 76 reporting institutions.
ORBIMED ADVISORS LLC is the largest reported institutional holder of RCEL, with approximately 82,010,995 shares worth $0.20B as of Q1 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of RCEL.
Our composite Smart Money Score for RCEL is 51 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
26 institutions opened new positions in RCEL during Q1 2026, while 16 fully exited. 39 added to existing positions and 8 trimmed.
RCEL institutional ownership rose by 182.91 percentage points quarter-over-quarter, with a net change of +10 holders.
The top 10 institutions account for 98.3% of all reported 13F value in RCEL, and the top 25 account for 99.5%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
AVITA Medical, Inc. (RCEL) Institutional Ownership